Shares of Bio-Techne Corp. TECH slipped 1.78% to $59.98 Tuesday, on what proved to be an all-around favorable trading session ...

The stock's fall snapped a three-day winning streak.

Corporation announced further advancements in its ongoing strategy to bring translational discoveries to patient care by ...

Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by leveraging RNAscope technology to address unmet ...

Equities research analysts at Evercore ISI assumed coverage on shares of Bio-Techne (NASDAQ:TECH – Get Free Report) in a ...

MINNEAPOLIS, March 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care ...

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, ...

Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.

ALZpath, Inc. (ALZpath), a leading developer of diagnostic tools and solutions for Alzheimer's disease and related dementias, announced the addition of Samantha Budd Haeberlein, PhD, to its board ...

Shares of Charles River Laboratories International Inc. slipped 3.37% to $161.35 Tuesday, on what proved to be an all-around ...

We recently published a list of Top 10 Stocks to Buy According to 12 West Capital Management. In this article, we are going ...